Dupont Capital Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-821
| Closed | -$283K | – | 1310 |
|
|
2019
Q3 | $283K | Buy |
821
+423
| +106% | +$146K | 0.01% | 1022 |
|
|
2019
Q2 | $366K | Buy |
398
+222
| +126% | +$204K | 0.01% | 920 |
|
|
2019
Q1 | $280K | Buy |
+176
| New | +$280K | 0.01% | 974 |
|
|
2017
Q4 | – | Sell |
-283
| Closed | -$804K | – | 1005 |
|
|
2017
Q3 | $804K | Hold |
283
| – | – | 0.02% | 573 |
|
|
2017
Q2 | $670K | Sell |
283
-310
| -52% | -$734K | 0.01% | 610 |
|
|
2017
Q1 | $1.5M | Buy |
+593
| New | +$1.5M | 0.03% | 416 |
|
|
2016
Q3 | – | Sell |
-240
| Closed | -$736K | – | 719 |
|
|
2016
Q2 | $736K | Buy |
240
+92
| +62% | +$282K | 0.02% | 513 |
|
|
2016
Q1 | $471K | Hold |
148
| – | – | 0.01% | 551 |
|
|
2015
Q4 | $762K | Sell |
148
-100
| -40% | -$515K | 0.02% | 520 |
|
|
2015
Q3 | $788K | Buy |
248
+36
| +17% | +$114K | 0.02% | 485 |
|
|
2015
Q2 | $846K | Hold |
212
| – | – | 0.02% | 457 |
|
|
2015
Q1 | $845K | Sell |
212
-53
| -20% | -$211K | 0.02% | 464 |
|
|
2014
Q4 | $1.3M | Sell |
265
-96
| -27% | -$470K | 0.02% | 433 |
|
|
2014
Q3 | $1.47M | Hold |
361
| – | – | 0.03% | 386 |
|
|
2014
Q2 | $1.46M | Sell |
361
-109
| -23% | -$440K | 0.02% | 427 |
|
|
2014
Q1 | $2.14M | Hold |
470
| – | – | 0.03% | 359 |
|
|
2013
Q4 | $1.65M | Sell |
470
-73
| -13% | -$256K | 0.03% | 402 |
|
|
2013
Q3 | $2.23M | Sell |
543
-80
| -13% | -$329K | 0.04% | 349 |
|
|
2013
Q2 | $2.47M | Buy |
+623
| New | +$2.47M | 0.05% | 328 |
|